Novel Concepts for the Estimation of Lifetime Cardiovascular Risk

Marco Zuin1,2, Claudio Bilato3, Pier Luigi Temporelli4

  • 1Department of Cardio-Thoraco-Vascular Sciences and Public Health, University of Padova, Padua, Italy. zuinml@yahoo.it.

Insights

Lifetime cardiovascular disease (CVD) risk assessment offers a more comprehensive view than short-term models, especially for younger individuals and women. This approach improves CVD prevention strategies by considering broader risk factors and competing risks.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Public Health

Background:

  • Cardiovascular diseases (CVDs) are a leading global cause of mortality and disability.
  • Current risk assessment models primarily focus on short-term (10-year) CVD risk.
  • Short-term risk estimates often underestimate the lifetime CVD risk, particularly in women and younger populations.

Purpose of the Study:

  • To review emerging strategies for estimating lifetime cardiovascular disease (CVD) risk.
  • To explore the clinical utility of lifetime CVD risk assessment in daily practice.
  • To highlight the benefits for both primary and secondary CVD prevention.

Main Methods:

  • Literature review of recent strategies for lifetime CVD risk estimation.
  • Analysis of how lifetime risk assessment incorporates traditional and non-traditional risk factors.
  • Consideration of competing risks in comprehensive CVD risk profiling.

Main Results:

  • Lifetime CVD risk assessment provides a more accurate and tailored evaluation of a patient's health status.
  • Individuals with low to moderate short-term risk often account for a significant proportion of CVD events.
  • Lifetime risk models offer a broader perspective beyond traditional short-term predictions.

Conclusions:

  • Estimating lifetime CVD risk is crucial for effective and personalized prevention strategies.
  • This approach can better identify individuals who may benefit from early or intensified interventions.
  • Lifetime CVD risk assessment enhances clinical decision-making in managing cardiovascular health.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
355
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
477
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
184
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
69
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
40
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
301